Press release from Companies

Publicerat: 2021-11-25 08:00:00

CS MEDICA A/S: CS MEDICA A/S: Publication of annual report

CS MEDICA A/S (”CS MEDICA” or the ”Company”) hereby publishes its annual report for the period October 2020 –September 2021, including the auditor’s report. The report is available as an attached document to this press release and on the Company’s website (www.cs-medica.com).
 


This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528) and the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 25-11-2021 08:00 CET.
 

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47

Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: "CSMED"). For more information about CS MEDICA cs-medica.com.

Läs mer hos Cision
Läs mer om CS MEDICA A/S